Ascletis Pharma Inc. announces that its partner Sagimet Biosciences, will present clinical and preclinical data on non-alcoholic steatohepatitis drug candidate TVB-2640 at the upcoming European Association for the Study of the Liver International Liver Congress™ 2020 in London, which has been postponed to 25-28 August..
March 31, 2020
· 1 min read